awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33410649-E495DAA8-B690-488B-AA20-AE5AF0415082
Q33410649-E495DAA8-B690-488B-AA20-AE5AF0415082
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33410649-E495DAA8-B690-488B-AA20-AE5AF0415082
Practical management of patients with myelofibrosis receiving ruxolitinib.
P2860
Q33410649-E495DAA8-B690-488B-AA20-AE5AF0415082
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33410649-E495DAA8-B690-488B-AA20-AE5AF0415082
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
63d2810d62fa3f54db6db2b38c3d56135e4ac748
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.